Literature DB >> 30068645

Nonsteroidal Anti-inflammatory Drugs Potently Inhibit the Replication of Zika Viruses by Inducing the Degradation of AXL.

Ting Pan1,2,3, Zhilin Peng1,2,3, Likai Tan1,2,3, Fan Zou1,2,3, Nan Zhou1,2,3, Bingfeng Liu1,2,3, Liting Liang1,2,3, Cancan Chen1,2,3, Jun Liu1,2,3, Liyang Wu1,2,3, Guangyan Liu1,2,3, Zhiqin Peng1,2,3, Weiwei Liu1,2,3, Xiancai Ma1,2,3, Junsong Zhang1,2,3, Xun Zhu2,4, Ting Liu1,2,5, Mengfeng Li2,4, Xi Huang1,2,5, Liang Tao6, Yiwen Zhang7,2,3, Hui Zhang7,2,3,4.   

Abstract

Zika virus (ZIKV) is genetically and biologically related to other Flaviviridae family members and has disseminated to many countries. It is associated with severe consequences, including the abnormal development of the neural system in fetuses and neurological diseases in adults. Therefore, the development of anti-ZIKV drugs is of paramount importance. Screening of generic drugs revealed that several nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen, naproxen, acetaminophen, and lornoxicam, potently inhibited the entry of Zika virus Env/HIV-1-pseudotyped viruses. They also significantly inhibited the replication of wild-type ZIKV both in cell lines and in primary human fetal endothelial cells. Interestingly, the NSAIDs exerted this inhibitory effect by potently reducing the expression of AXL, the entry cofactor of ZIKV. Further studies showed that the NSAIDs downregulated the prostaglandin E2/prostaglandin E receptor 2 (EP2)/cAMP/protein kinase A (PKA) signaling pathway and reduced PKA-dependent CDC37 phosphorylation and the interaction between CDC37 and HSP90, which subsequently facilitated CHIP/ubiquitination/proteasome-mediated AXL degradation. Taken together, our results highlight a new mechanism of action of antiviral agents which may assist in designing a convenient strategy for treating ZIKV-infected patients.IMPORTANCE Zika virus (ZIKV) infection, which causes congenital malformations, including microcephaly and other neurological disorders, has attracted global attention. We observed that several NSAIDs significantly inhibited ZIKV infection. Based on our observations, we propose a novel mechanism of action of antiviral compounds which involves the blockade of virus entry via degradation of the entry cofactor. Furthermore, NSAIDs can be practically used for preventing ZIKV infection in pregnant women, as certain NSAIDs, including ibuprofen and acetaminophen, are considered clinically safe.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  AXL; NSAID; ZIKV; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 30068645      PMCID: PMC6158411          DOI: 10.1128/JVI.01018-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).

Authors:  S Mark Roe; Maruf M U Ali; Philippe Meyer; Cara K Vaughan; Barry Panaretou; Peter W Piper; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Cell       Date:  2004-01-09       Impact factor: 41.582

2.  Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.

Authors:  Hetian Lei; Annapurna Venkatakrishnan; Soyoung Yu; Andrius Kazlauskas
Journal:  J Biol Chem       Date:  2007-01-03       Impact factor: 5.157

3.  Evidence of Sexual Transmission of Zika Virus.

Authors:  Eric D'Ortenzio; Sophie Matheron; Yazdan Yazdanpanah; Xavier de Lamballerie; Bruno Hubert; Géraldine Piorkowski; Marianne Maquart; Diane Descamps; Florence Damond; Isabelle Leparc-Goffart
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

4.  Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.

Authors:  Gnana Prakasam Krishnamoorthy; Teresa Guida; Luigi Alfano; Elvira Avilla; Massimo Santoro; Francesca Carlomagno; Rosa Marina Melillo
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

5.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

6.  AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses.

Authors:  Audrey Stéphanie Richard; Byoung-Shik Shim; Young-Chan Kwon; Rong Zhang; Yuka Otsuka; Kimberly Schmitt; Fatma Berri; Michael S Diamond; Hyeryun Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 7.  Prostaglandin E receptors.

Authors:  Yukihiko Sugimoto; Shuh Narumiya
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

8.  Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.

Authors:  Takako Tabata; Matthew Petitt; Henry Puerta-Guardo; Daniela Michlmayr; Chunling Wang; June Fang-Hoover; Eva Harris; Lenore Pereira
Journal:  Cell Host Microbe       Date:  2016-07-18       Impact factor: 21.023

9.  Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells.

Authors:  Tomasz J Nowakowski; Alex A Pollen; Elizabeth Di Lullo; Carmen Sandoval-Espinosa; Marina Bershteyn; Arnold R Kriegstein
Journal:  Cell Stem Cell       Date:  2016-03-30       Impact factor: 24.633

10.  Male-to-Male Sexual Transmission of Zika Virus--Texas, January 2016.

Authors:  D Trew Deckard; Wendy M Chung; John T Brooks; Jessica C Smith; Senait Woldai; Morgan Hennessey; Natalie Kwit; Paul Mead
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-04-15       Impact factor: 17.586

View more
  13 in total

Review 1.  Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Viruses       Date:  2020-09-26       Impact factor: 5.048

2.  The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.

Authors:  Yiwen Zhang; Yingshi Chen; Yuzhuang Li; Feng Huang; Baohong Luo; Yaochang Yuan; Baijin Xia; Xiancai Ma; Tao Yang; Fei Yu; Jun Liu; Bingfeng Liu; Zheng Song; Jingliang Chen; Shumei Yan; Liyang Wu; Ting Pan; Xu Zhang; Rong Li; Wenjing Huang; Xin He; Fei Xiao; Junsong Zhang; Hui Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

Review 3.  Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go.

Authors:  Juan-Carlos Saiz
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-30

4.  USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.

Authors:  Ting Pan; Zheng Song; Liyang Wu; Guangyan Liu; Xiancai Ma; Zhilin Peng; Mo Zhou; Liting Liang; Bingfeng Liu; Jun Liu; Junsong Zhang; Xuanhong Zhang; Ryan Huang; Jiacong Zhao; Yonghong Li; Xuemei Ling; Yuewen Luo; Xiaoping Tang; Weiping Cai; Kai Deng; Linghua Li; Hui Zhang
Journal:  Elife       Date:  2019-08-09       Impact factor: 8.140

5.  Aspirin and 5-Aminoimidazole-4-carboxamide Riboside Attenuate Bovine Ephemeral Fever Virus Replication by Inhibiting BEFV-Induced Autophagy.

Authors:  Hsu-Hung Tseng; Wei-Ru Huang; Ching-Yuan Cheng; Hung-Chuan Chiu; Tsai-Ling Liao; Brent L Nielsen; Hung-Jen Liu
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

6.  Autophagy Contributes to Host Immunity and Protection against Zika Virus Infection via Type I IFN Signaling.

Authors:  Yuyi Huang; Yujie Wang; Shuhui Meng; Zhuohang Chen; Haifan Kong; Ting Pan; Gen Lu; Xuefeng Li
Journal:  Mediators Inflamm       Date:  2020-04-28       Impact factor: 4.711

7.  Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.

Authors:  Jie Yuan; Jianchen Yu; Yun Huang; Zhenjian He; Jia Luo; Yun Wu; Yingchun Zheng; Jueheng Wu; Xun Zhu; Haihe Wang; Mengfeng Li
Journal:  BMC Med       Date:  2020-07-31       Impact factor: 8.775

Review 8.  Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection.

Authors:  Marco P Alves; Nathalie J Vielle; Volker Thiel; Stephanie Pfaender
Journal:  Viruses       Date:  2018-10-30       Impact factor: 5.048

Review 9.  Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus.

Authors:  Subhash C Basak; Subhabrata Majumdar; Ashesh Nandy; Proyasha Roy; Tathagata Dutta; Marjan Vracko; Apurba K Bhattacharjee
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-16

10.  C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3.

Authors:  Yun Wu; Xinyu Yang; Zhicheng Yao; Xinhuai Dong; Danrui Zhang; Yiwen Hu; Shihao Zhang; Jiajie Lin; Jiahui Chen; Shu An; Hengming Ye; Shuqing Zhang; Ziying Qiu; Zhenjian He; Mingxing Huang; Guohong Wei; Xun Zhu
Journal:  PLoS Negl Trop Dis       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.